Gene · 6195
Papers3,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Potential effects of a human milk oligosaccharide 6'-sialyllactose on angiotensin II-induced aortic aneurysm via p90RSK/TGF-β/SMAD2 signaling pathway. | Arch Pharm Res | 2024 | 39463210 | PubTator, text mining | PubMed |
| Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis. | PLoS One | 2024 | 39436906 | PubTator, text mining | PubMed |
| A web portal for exploring kinase-substrate interactions. | NPJ Syst Biol Appl | 2024 | 39362876 | PubTator, text mining | PubMed |
| RPS6KA1 is a histone acetylation-related oncoprotein in acute myeloid leukemia which is targeted by afzelin. | BMC Cancer | 2024 | 39333927 | PubTator, text mining | PubMed |
| Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer. | Cells | 2024 | 39329730 | PubTator, text mining | PubMed |
| Breast cancer promotes the expression of neurotransmitter receptor related gene groups and image simulation of prognosis model. | SLAS Technol | 2024 | 39218304 | PubTator, text mining | PubMed |
| PPP1R14B-mediated phosphorylation enhances protein stability of RPS6KA1 to promote hepatocellular carcinoma tumorigenesis. | Biochim Biophys Acta Mol Cell Res | 2024 | 39216602 | PubTator, text mining | PubMed |
| Comprehensive analysis of shared risk genes and immunity-metabolisms between non-alcoholic fatty liver disease and atherosclerosis via bulk and single-cell transcriptome analyses. | Heliyon | 2024 | 39165965 | PubTator, text mining | PubMed |
| Construction and validation of a SASP-related prognostic signature in patients with acute myeloid leukaemia. | J Cell Mol Med | 2024 | 39159071 | PubTator, text mining | PubMed |
| Fasting-induced miR-7a-5p in AgRP neurons regulates food intake. | Metabolism | 2024 | 38942170 | PubTator, text mining | PubMed |
| Phosphorylation of caspase-8 by RSKs via organ-constrained effects controls the sensitivity to TNF-induced death. | Cell Death Discov | 2024 | 38789425 | PubTator, text mining | PubMed |
| Estrogen Receptor Is Required for Metformin-Induced Apoptosis in Breast Cancer Cells Under Hyperglycemic Conditions. | Breast Cancer (Auckl) | 2024 | 38779416 | PubTator, text mining | PubMed |
| Structure-Guided Discovery and Preclinical Assessment of Novel (Thiophen-3-yl)aminopyrimidine Derivatives as Potent ERK1/2 Inhibitors. | J Med Chem | 2024 | 38613499 | PubTator, text mining | PubMed |
| Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis. | Front Med (Lausanne) | 2024 | 38606153 | PubTator, text mining | PubMed |
| Engagement of AKT and ERK signaling pathways facilitates infection of human neuronal cells with West Nile virus. | J Virus Erad | 2024 | 38601702 | PubTator, text mining | PubMed |
| Activation of MAP Kinase Pathway by Polyisoprenylated Cysteinyl Amide Inhibitors Causes Apoptosis and Disrupts Breast Cancer Cell Invasion. | Biomedicines | 2024 | 38540084 | PubTator, text mining | PubMed |
| p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer. | BMC Cancer | 2024 | 38373988 | PubTator, text mining | PubMed |
| Identification of RSK substrates using an analog-sensitive kinase approach. | J Biol Chem | 2024 | 38342435 | PubTator, text mining | PubMed |
| Decoding leukemia at the single-cell level: clonal architecture, classification, microenvironment, and drug resistance. | Exp Hematol Oncol | 2024 | 38291542 | PubTator, text mining | PubMed |
| Study of Drug Targets Associated With Oncogenesis and Cancer Cell Survival and the Therapeutic Activity of Engineered Ashwagandha Extract Having Differential Withanolide Constitutions. | Integr Cancer Ther | 2024 | 38281118 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6195/papers?page=5